C4A Complement Pathway Decouples from C1Q in First-Episode Psychosis

Dissecting Immune Dysregulation in Early Psychosis

The clinical management of first-episode psychosis remains a significant challenge for psychiatrists and primary care physicians, as standard antipsychotic therapies often fail to address the underlying neurobiological drivers of the disease. Emerging evidence suggests that a pro-inflammatory state and reduced antioxidant status are prevalent in these patients, potentially serving as targets for early intervention [1]. While peripheral markers like C-reactive protein and various interleukins are frequently elevated, the relationship between systemic inflammation and central nervous system changes remains complex [2]. Disruption of the blood-cerebrospinal fluid barrier (the physiological interface that regulates the movement of molecules between the systemic circulation and the brain) has been observed in a significant portion of patients with schizophrenia-spectrum disorders, particularly in males with severe positive symptoms [3]. Furthermore, the inflammatory hypothesis of schizophrenia links immune activation to aberrant glutamate-dopamine interactions and altered synaptic density [4]. A new study now offers specific insights into how components of the complement system (a part of the innate immune system that enhances the ability of antibodies and phagocytic cells to clear pathogens and damaged cells) behave differently within the brain and the blood during the initial stages of psychosis.

Divergent Roles of C4A and C4B Paralogs

The complement system involves two highly similar proteins known as C4A and C4B, which are paralogs (genes that are related by duplication within a genome but may evolve different functions). Although these proteins share high sequence similarity, they possess distinct biological roles and clinical relevance in psychiatric pathology. Specifically, C4A is implicated in synaptic pruning, the physiological process where the brain eliminates redundant or extra synapses to refine neural circuitry during development. Unlike C4B, elevated expression of the C4A gene is strongly associated with an increased risk for schizophrenia, suggesting that excessive synaptic refinement during critical adolescent developmental windows may contribute to the neurobiological architecture of the disorder. To investigate these dynamics in the earliest stages of clinical presentation, researchers conducted a comprehensive analysis of 113 patients with first-episode psychosis and 90 healthy controls. The study utilized a multi-compartment approach, measuring levels of C4A, C4B, and C1Q (the initiating protein of the classical complement pathway) within the cerebrospinal fluid. Furthermore, the team quantified 48 inflammation-related proteins in both the cerebrospinal fluid and plasma to map the broader immune landscape. By comparing these two biological compartments, the authors sought to determine whether the immune signatures observed in the central nervous system are mirrored in systemic circulation, providing a clearer picture of the inflammatory milieu during a patient's first psychotic break.

Loss of C1Q-C4A Coordination in the Central Nervous System

The study identified a fundamental shift in how complement proteins interact within the central nervous system during the onset of psychiatric illness. In the 90 healthy controls, the researchers observed a consistent physiological relationship where both C4A and C4B were positively associated with C1Q, the protein that initiates the classical complement pathway. Specifically, cerebrospinal fluid C4A was positively associated with C1Q (z = 0.41, p < 0.001), and cerebrospinal fluid C4B was similarly associated with C1Q (z = 0.48, p < 0.001). This coordination suggests that under normal conditions, these proteins function as a synchronized unit to manage immune surveillance and synaptic maintenance within the brain environment. This regulatory balance appears to collapse during the initial stages of psychosis. In the cohort of 113 patients with first-episode psychosis, the cerebrospinal fluid C1Q-C4A association was abolished (z = 0.09, p = 0.40). This decoupling is highly specific, as it represents a breakdown in the expected link between the initiator protein and the C4A paralog, which is the specific variant linked to synaptic pruning. For clinicians, this finding is significant because it suggests that the neurobiological pathology of psychosis involves more than just a simple increase in inflammatory markers; it involves a structural failure of the immune signaling cascade. The loss of this association indicates that C4A may be acting independently of its usual regulatory triggers, potentially leading to the aberrant synaptic elimination often observed in the schizophrenic brain.

Compartment-Specific Immune Network Alterations

The researchers utilized permutation tests on directional mean differences (a statistical method used to determine if the observed difference in protein levels between groups is greater than what would be expected by chance) to evaluate how complement protein levels shifted in patients compared to healthy individuals. This analysis revealed a robust positive directional shift for C4A in first-episode psychosis (z = 3.81, p < 0.0001), indicating a significant elevation of this specific protein during the early stages of the disorder. In contrast, C4B showed a non-significant negative shift in first-episode psychosis (z = -2.64, p > 0.9), further highlighting the divergent behavior of these two closely related paralogs. These findings were not limited to the central nervous system, as the overall C4A directional shift observed in the cerebrospinal fluid was largely preserved in plasma, suggesting that the elevation of C4A may be detectable through peripheral blood sampling. The study also examined how these complement proteins interacted with a broader panel of 48 inflammatory markers to map the immune landscape of the brain. In healthy controls, C4A levels showed predominantly negative correlations with inflammatory markers in the cerebrospinal fluid, whereas C4B and C1Q exhibited mostly positive correlations with inflammatory markers in the same compartment. This baseline architecture suggests that C4A normally functions in a distinct regulatory niche compared to C4B and C1Q. However, the data indicate that C4A-inflammatory protein relationships are selectively altered in first-episode psychosis, representing a departure from typical immune signaling patterns. While some C4A trends were consistent across the body, the structure of complement-protein interactions differed markedly between the cerebrospinal fluid and plasma compartments, suggesting that the immune dysregulation driving early psychosis involves complex, tissue-specific network changes rather than a uniform systemic inflammatory response.

References

1. Fraguas D, Díaz‐Caneja CM, Ayora M, et al. Oxidative Stress and Inflammation in First-Episode Psychosis: A Systematic Review and Meta-analysis. Schizophrenia Bulletin. 2018. doi:10.1093/schbul/sby125

2. Baumeister D, Akhtar R, Ciufolini S, Pariante CM, Mondelli V. Childhood trauma and adulthood inflammation: a meta-analysis of peripheral C-reactive protein, interleukin-6 and tumour necrosis factor-α. Molecular Psychiatry. 2015. doi:10.1038/mp.2015.67

3. Campana M, Yakimov V, Moussiopoulou J, et al. Association of symptom severity and cerebrospinal fluid alterations in recent onset psychosis in schizophrenia-spectrum disorders - An individual patient data meta-analysis.. Brain, behavior, and immunity. 2024. doi:10.1016/j.bbi.2024.04.011

4. Bartolomeis AD, Barone A, Vellucci L, et al. Linking Inflammation, Aberrant Glutamate-Dopamine Interaction, and Post-synaptic Changes: Translational Relevance for Schizophrenia and Antipsychotic Treatment: a Systematic Review. Molecular Neurobiology. 2022. doi:10.1007/s12035-022-02976-3